C1orf87 | Chromosome 1 open reading frame 87 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31368/67807_B_8_2_rna_selected_60x60.jpg) | Group enriched |
C2orf81 | Chromosome 2 open reading frame 81 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49564/112471_A_3_3_rna_selected_60x60.jpg) | Group enriched |
CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/6558/22094_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CADM3 | Cell adhesion molecule 3 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2981/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2981/8435_B_7_8_rna_selected_60x60.jpg) | Group enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | ![](/images/40725/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40725/88884_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/53973/127623_A_6_2_rna_selected_60x60.jpg) | Group enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/26307/57633_A_5_8_rna_selected_60x60.jpg) | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38569/141858_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17518/40857_B_2_5_rna_selected_60x60.jpg) | Group enriched |
CCDC19 | Coiled-coil domain containing 19 | | | | ![](/images_static/rna_center.gif) | ![](/images/43618/102476_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CCDC37 | Coiled-coil domain containing 37 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46354/103276_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CCDC96 | Coiled-coil domain containing 96 | Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47546/146625_B_3_5_rna_selected_60x60.jpg) | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | | ![](/images/3796/11202_A_9_6_rna_selected_60x60.jpg) | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16110/36118_A_9_1_rna_selected_60x60.jpg) | Group enriched |
CD207 | CD207 molecule, langerin | CD markers Disease related genes Predicted membrane proteins
| | ![](/images/11216/if_selected_60x60.jpg) | ![](/images/11216/ihc_cell_selected_60x60.jpg) | ![](/images/11216/27980_B_8_1_rna_selected_60x60.jpg) | Group enriched |
CD72 | CD72 molecule | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2505/6522_A_7_1_rna_selected_60x60.jpg) | Group enriched |
CDH17 | Cadherin 17, LI cadherin (liver-intestine) | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/23614/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/23616/52784_B_1_6_rna_selected_60x60.jpg) | Group enriched |
CDHR2 | Cadherin-related family member 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/17053/ihc_cell_selected_60x60.jpg) | ![](/images/17053/38962_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CDX1 | Caudal type homeobox 1 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images/55196/ihc_cell_selected_60x60.jpg) | ![](/images/55196/127987_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | ![](/images/2221/5839_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/21/18_B_7_1_rna_selected_60x60.jpg) | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11041/27138_B_8_3_rna_selected_60x60.jpg) | Group enriched |
CEACAM7 | Carcinoembryonic antigen-related cell adhesion molecule 7 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/69621/152549_A_5_7_rna_selected_60x60.jpg) | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12023/30143_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Group enriched |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10575/25814_A_2_7_rna_selected_60x60.jpg) | Group enriched |
CHST5 | Carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 5 | Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43804/96382_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CKMT2 | Creatine kinase, mitochondrial 2 (sarcomeric) | Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/51880/ihc_cell_selected_60x60.jpg) | ![](/images/51880/120103_B_7_6_rna_selected_60x60.jpg) | Group enriched |
CLCA1 | Chloride channel accessory 1 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/52787/ihc_cell_selected_60x60.jpg) | ![](/images/59301/139587_B_5_1_rna_selected_60x60.jpg) | Group enriched |
CLCA4 | Chloride channel accessory 4 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17045/39405_B_8_2_rna_selected_60x60.jpg) | Group enriched |
CLDN18 | Claudin 18 | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/13243/28311_B_2_5_rna_selected_60x60.jpg) | Group enriched |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4906/19765_B_7_4_rna_selected_60x60.jpg) | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted membrane proteins
| | ![](/images/14044/if_selected_60x60.jpg) | ![](/images/14044/ihc_cell_selected_60x60.jpg) | ![](/images/3789/10114_B_2_1_rna_selected_60x60.jpg) | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33689/80801_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CLIC3 | Chloride intracellular channel 3 | Plasma proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/5963/137904_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CNDP1 | Carnosine dipeptidase 1 (metallopeptidase M20 family) | Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/8933/24067_A_4_5_rna_selected_60x60.jpg) | Group enriched |
CNFN | Cornifelin | | | ![](/images/53997/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49073/110082_B_8_4_rna_selected_60x60.jpg) | Group enriched |
CNTNAP2 | Contactin associated protein-like 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2739/8002_B_2_1_rna_selected_60x60.jpg) | Group enriched |
CPS1 | Carbamoyl-phosphate synthase 1, mitochondrial | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | ![](/images/21400/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3781/10124_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/2659/ihc_cell_selected_60x60.jpg) | ![](/images/2659/6600_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/5036/ihc_cell_selected_60x60.jpg) | ![](/images/5036/15290_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CSRP3 | Cysteine and glycine-rich protein 3 (cardiac LIM protein) | Cytoskeleton related proteins Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/42581/ihc_cell_selected_60x60.jpg) | ![](/images/42581/108075_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/47320/103192_B_8_6_rna_selected_60x60.jpg) | Group enriched |
CTSE | Cathepsin E | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12940/129727_B_1_8_rna_selected_60x60.jpg) | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42432/123485_A_8_2_rna_selected_60x60.jpg) | Group enriched |
CXorf67 | Chromosome X open reading frame 67 | | | | ![](/images_static/rna_center.gif) | ![](/images/4003/141639_A_2_1_rna_selected_60x60.jpg) | Group enriched |
CYP11A1 | Cytochrome P450, family 11, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/16436/142443_B_8_5_rna_selected_60x60.jpg) | Group enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/33671/76711_B_9_7_rna_selected_60x60.jpg) | Group enriched |
CYP4F2 | Cytochrome P450, family 4, subfamily F, polypeptide 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | ![](/images/14048/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/58960/133524_B_8_6_rna_selected_60x60.jpg) | Group enriched |
DAO | D-amino-acid oxidase | Enzymes Predicted secreted proteins
| | ![](/images/38653/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38654/80366_B_7_8_rna_selected_60x60.jpg) | Group enriched |